학술논문
Outcomes of Patients with Child-Pugh B and Unresectable Hepatocellular Carcinoma Undergoing First-Line Systemic Treatment with Sorafenib, Lenvatinib, or Atezolizumab Plus Bevacizumab
Document Type
Article
Author
Kikugawa, C.; Uchikawa, S.; Kawaoka, T.; Kinami, T.; Yano, S.; Amioka, K.; Naruto, K.; Ando, Y.; Yamaoka, K.; Tsuge, M.; Oka, S.; Kosaka, Y.; Ohya, K.; Mori, N.; Takaki, S.; Tsuji, K.; Kouno, H.; Kohno, H.; Morio, K.; Moriya, T.; Nonaka, M.; Aisaka, Y.; Masaki, K.; Honda, Y.; Naeshiro, N.; Hiramatsu, A.; Aikata, H.
Source
In: Oncology (Switzerland) . (Oncology (Switzerland), 1 March 2024, 102(3):239-251)
Subject
Language
English
ISSN
14230232
00302414
00302414